NGN Capital Overview

  • Investor Type
  • Venture Capital
  • Status
  • Active
  • Professionals
  • 7
Professionals
  • Investments
  • 58
  • Portfolio
  • 7
  • Exits
  • 27
Exits

NGN Capital General Information

Description

NGN Capital is a venture capital firm dedicated to healthcare investing, focusing on ventures with the potential to achieve above average private equity returns with an emphasis on later stage investments. The firm is based in New York, New York and was founded in 2003.

Contact Information

Year Founded
2003
Investor Status
Actively Seeking New Investments
Primary Investor Type
Venture Capital
Primary Office
  • 369 Lexington Avenue
  • 26th Floor
  • New York, NY 10017
  • United States
+1 (212) 000-0000

NGN Capital Investments (58)

Company Name Deal Date Deal Type Deal Size Industry Company Stage Lead Partner
OptiScan 20-Mar-2019 Later Stage VC 0000 Monitoring Equipment Bankruptcy: Admin/Reorg 0000000 0000000000
0000000 0000000000 05-Jul-2017 00000 00000 000.00 Biotechnology Generating Revenue 00000 000000 00.0
0000000 0000000000 07-Jan-2016 00000 00000 0000 Biotechnology Generating Revenue 00000 000000 00.0
000000 0000000 23-Jul-2014 00000 00000 000.00 Biotechnology Generating Revenue/Not Profitable
0000000 0000000000 12-Mar-2014 00000 00000 000.00 Biotechnology Generating Revenue 00000 000000 00.0
0000 0000000 00000 05-Mar-2014 00000 00000 00.00 Business/Productivity Software Generating Revenue
000000000 05-Mar-2013 00000 00000 000.00 Surgical Devices Generating Revenue 00000 000000 00.0
0000000000 12-Dec-2012 00000 00000 0000 Other Healthcare Technology Systems Generating Revenue 0000000 0000000000
PIN Pharma 01-Jan-2012 Early Stage VC 00.000 Biotechnology Generating Revenue 0000 0000000
SpineView 21-Oct-2011 Later Stage VC 0000 Surgical Devices Out of Business
You’re viewing 10 of 58 investments. Get the full list »
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

NGN Capital Exits (27)

Company Name Exit Date Exit Type Exit Size
OptiScan 02-Jun-2020 Bankruptcy: Admin/Reorg
000000 0000000 06-Mar-2020 000 00000
0000000 0000000000 01-Aug-2018 000000000000000000 00000
0000000 000000 23-Jan-2017 000000000000000000 00000
000000000 01-Oct-2016 000000000000000000 00.000
000000 000000 30-Sep-2016 000
000 0000000 01-Sep-2015 000 00 00000000
00000 0000 0000000 06-Oct-2014 000000000000000000 00000
Endosense 19-Aug-2013 Merger/Acquisition 00000
EKOS 08-Jul-2013 Merger/Acquisition 00000
You’re viewing 10 of 27 exits. Get the full list »

NGN Capital Fund Performance

Fund Name Vintage Size Dry Powder DPI RVPI TVPI IRR

This information is available in the PitchBook Platform. To explore NGN Capital‘s full profile, request access.

Request a free trial

NGN Capital Investments by Industry, Year, and Region

Investments by Industry

Investments by Year

Investments by Region

PitchBook’s data visualizations quickly surface an investor’s historical investments—showing a breakdown of activity by industry, year and region.

Request a free trial

NGN Capital Team (20)

Name Title Deals Funds Boards Office
Alexander Cuomo Chief Financial Officer New York, NY
Kenneth Abramowitz Co-Founder & Managing General Partner 00 0 0 New York, NY
John Costantino JD Managing General Partner 0 0 0 New York, NY
Peter Johann Ph.D Managing General Partner 0 0 0 Heidelberg, Germany
Ivica Cerina Ph.D Partner 0 New York, NY
You’re viewing 5 of 20 team members. Get the full list »

NGN Capital Co-Investors (12)

Name With Exits Lead Partner Series Industry
Arcus Ventures 1 0 0 Series chart Industry bar
FORBION 0 0 0 Series chart Industry bar
Tiger Global Management 0 0 0 Series chart Industry bar
Wexford Capital 0 0 0 Series chart Industry bar
b-to-v Partners 0 0 0 Series chart Industry bar
You’re viewing 5 of 12 co-investors. Get the full list »